Last quarter (Q1 2026), CytoDyn's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, CytoDyn's net income was $-5.54M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	$ -5.92M	$ 0.00	$ 0.00	$ 266.00K	$ 0.00
Gross Profit	$ -18.00K	$ -29.00K	$ -175.00K	$ 213.00K	$ -1.80M
Operating Expenses	$ -11.34M	$ 18.06M	$ 40.40M	$ 72.13M	$ 92.75M
Depreciation and Amortization	$ 18.00K	$ 29.00K	$ 175.00K	$ 781.00K	$ 1.80M
EBITDA	$ 8.62M	$ -18.03M	$ -40.40M	$ -194.97M	$ -92.75M
Operating Income	$ 11.32M	$ -18.06M	$ -40.58M	$ -145.40M	$ -104.60M
Other Income/Expenses	$ -7.58M	$ -31.78M	$ -39.25M	$ -65.42M	$ -50.08M
Pretax Income	$ 3.75M	$ -49.84M	$ -79.82M	$ -210.82M	$ -154.67M
Net Income	$ 3.75M	$ -49.84M	$ -79.82M	$ -210.82M	$ -174.02M
Per Share Metrics
Basic EPS	$ 0.00	$ -0.05	$ -0.10	$ -0.43	$ -0.30
Diluted EPS	$ 0.00	$ -0.05	$ -0.10	$ -0.43	$ -0.30
Weighted Average Shares Outstanding	1.21B	969.51M	836.53M	676.90M	587.59M
Weighted Average Shares Outstanding (Diluted)	1.24B	969.51M	836.53M	676.90M	587.59M

Currency in USD

CytoDyn Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing